North America Healthcare Analytical Testing Services Market (2025-2030)
The North America Healthcare Analytical Testing Services Market was valued at $690.7 Million in 2025 and projected to reach to $1176.6 Million by 2030, representing a compound annual growth rate of 11.2%. The North American Healthcare Analytical Testing Services Market is poised for robust expansion through 2030, driven by escalating regulatory pressures, increased outsourcing of testing functions, and the proliferation of complex biologics and specialty pharmaceuticals.
North America Healthcare Analytical Testing Services Market Trends and Insights
- This segment encompasses comprehensive testing and quality assurance protocols for pharmaceutical, biotechnology, and medical device raw materials, ensuring compliance with regulatory standards and safety requirements.
- Raw Material Testing Services is projected to expand significantly, reaching $1,176.6 million by 2030, driven by increasing regulatory scrutiny, supply chain complexity, and the need for stringent quality control across healthcare manufacturing. The growth trajectory of Raw Material Testing Services reflects heightened demand for analytical validation across ingredient sourcing, contamination detection, and potency verification.
- Raw Material Testing Services providers are increasingly adopting advanced analytical technologies, including chromatography, spectroscopy, and microbial testing, to meet evolving pharmaceutical and medical device standards.
- Between 2025 and 2030, Raw Material Testing Services will benefit from expanded outsourcing trends, globalization of supply chains, and stricter enforcement of quality standards by regulatory bodies worldwide..
Key Market Statistics
- CAGR (2025-2030) 11.2% CAGR
- Market Size, 2025 ~USD 690.7 Million
- Forecast, 2030 ~USD 1176.6 Million
- Geography North America
North America Healthcare Analytical Testing Services Market Overview
Dominant US Market Leadership :
The US commands the North American market with $4,916.8 million in 2025, representing over 87% of the regional market share. This dominance is driven by stringent FDA regulations, advanced pharmaceutical manufacturing infrastructure, and significant R&D investments in biotechnology and medical devices.
Strong Regional Growth Trajectory :
North America's 11.2% CAGR outpaces the global average of 10.8%, reflecting accelerated demand for raw material testing services. This growth is fueled by increasing regulatory compliance requirements, expansion of contract manufacturing organizations (CMOs), and heightened quality assurance standards across the healthcare sector.
Canada's Emerging Contribution :
Canada represents a secondary but growing market at $453.6 million in 2025, supported by Health Canada's rigorous pharmaceutical approval processes and a robust biotech ecosystem. The country's proximity to the US and integrated supply chains enhance cross-border testing service demand.
Regulatory Compliance as Market Driver :
North American pharmaceutical and medical device manufacturers face the world's most stringent regulatory frameworks (FDA, Health Canada). This creates sustained demand for comprehensive raw material testing, quality control, and documentation services to ensure product safety and market approval.
North America Healthcare Analytical Testing Services Market Dynamics
- The region's mature healthcare infrastructure, combined with stringent quality standards, creates a premium market for advanced analytical testing capabilities.
- Investment in laboratory automation and digital compliance solutions will further accelerate market growth. Canada's integration with North American supply chains and the US pharmaceutical sector's continued dominance ensure sustained demand for raw material testing services.
- Emerging trends including personalized medicine, biosimilar development, and medical device innovation will expand testing scope and complexity.
- The market is expected to reach $1,176.6 million by 2030, reflecting the region's commitment to maintaining the highest standards of product quality and regulatory compliance..
Related Ecosystem
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Key Takeaways
- Raw Material Testing Services market valued at $690.7 million in 2025, with projected growth to $1,176.6 million by 2030 at 11.2% CAGR.
- Raw Material Testing Services demand is driven by stringent regulatory requirements, pharmaceutical supply chain complexity, and quality assurance mandates.
- Raw Material Testing Services providers are investing in advanced analytical technologies and automation to enhance testing accuracy and throughput.
- Raw Material Testing Services outsourcing is accelerating as pharmaceutical and biotech companies prioritize core competencies over in-house testing infrastructure.
Healthcare Analytical Testing Services Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ENVIRONMENTAL MONITORING SERVICES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10.8% from 2025 to 2030 |
| Largest Segment | BIOANALYTICAL TESTING SERVICES (Type) |
| Market Size Base Year (Billions) | ~USD 7.47 (2025) |
| Revenue Forecast (Billions) | ~USD 12.48 (2030) |
| Segments Covered | Type |
North America Healthcare Analytical Testing Services Market Report Segmentation
1 segment dimensions are covered across the global market.
By Type
- Analytical Standard Characterization Services
- Batch-Release Testing Services
- Bioanalytical Testing Services
- Bioassay Testing Services
- Biomarker Testing Services
- Cleaning Validation & Method Development Services
- Complete Compendial Testing Services
- Container Testing Services
- Environmental Monitoring Services
- Extractables/Leachables Method Development & Validation Services
- Genomic Testing Services
- Heavy Metal Testing Services
- Immunogenicity & Neutralizing Antibody Testing Services
- Laser Particle Size Analysis Services
- Method Development & Validation Services
- Microbial Testing Services
- Optical Characterization Services
- Other Analytical Testing Services
- Other Bioanalytical Testing Services
- Other Method Development & Validation Services
- Other Physical Characterization Services
- Other Raw Material Testing Services
- Pharmacokinetic & Toxicokinetic Testing Services
- Physical Characterization Services
- Process Impurity Method Development & Validation Services
- Raw Material Testing Services
- Stability Testing Services
- Stability-Indicating Method Validation Services
- Surface Area Analysis Services
- Technical Consulting Services
- Thermal Analysis Services
- Water Content Analysis Services
Target Audience
- Pharmaceutical Manufacturers : Require comprehensive raw material testing data to optimize supplier qualification, ensure FDA compliance, and reduce time-to-market for new drug formulations. North American market insights inform outsourcing decisions and testing service provider selection.
- Biotechnology Companies : Need specialized analytical testing for complex biologics, biosimilars, and cell/gene therapies. Market intelligence supports vendor evaluation, capacity planning, and regulatory strategy development for North American product launches.
- Medical Device Manufacturers : Depend on rigorous raw material and component testing to meet FDA device classification requirements. Regional market data informs testing protocol development, quality assurance budgeting, and contract laboratory partnerships.
- Contract Manufacturing Organizations (CMOs) : Operate in North America's high-compliance environment and require detailed market insights to benchmark testing service costs, identify capacity gaps, and develop competitive service offerings for pharmaceutical clients.
- Testing Laboratory Service Providers : Need North American market segmentation, growth forecasts, and competitive landscape data to guide laboratory expansion, technology investment, accreditation priorities, and client acquisition strategies in the region.
Key Companies in the North America Healthcare Analytical Testing Services Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| PATHEON INC | Netherlands | Private Company | Drug product services (finished dosage manufacturing and packaging),Pharmaceutical development services,Drug substance services (API and biologics), |
| BIOMERIEUX S.A. | France | Public Company | Clinical microbiology (VITEK, BACT/ALERT, CHROMID, culture media),Syndromic and molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome), |
| EXOVA GROUP PLC | United Kingdom | Private Company | Materials, mechanical, metallurgical and components performance testing,Environmental, infrastructure, health and fire testing and certification,Food and pharmaceutical analysis, |
| TSI INC | China | Public Company | Core Tsingtao Beer,Laoshan and Other Value Brands,Premium / Specialty (Hans, TSINGTAO 1903 Pubs, Tsingtao Prince, museum-linked SKUs), |
| UNILABS | Switzerland | Private Company | Laboratory testing (routine and specialty),Medical imaging services,Pathology and centres of excellence, |
| EUROFINS SCIENTIFIC SE | Luxembourg | Public Company | Food and Feed Testing,Environment Testing,Biopharma and Clinical Diagnostics, |
| INTERTEK GROUP PLC | United Kingdom | Public Company | Consumer Products,Industry and Infrastructure,World of Energy, |
| ICON PLC | Ireland | Public Company | Clinical development services (Phase I–IV, peri/post-approval, site and patient access),Data solutions, medical imaging, real world intelligence,Laboratory and testing services (bioanalytical, biomarker, vaccine, central labs, GMP), |
| IQVIA INC. | United States | Public Company | Technology & Analytics Solutions,Research & Development Solutions,Contract Sales & Medical Solutions, |
| WUXI APPTEC CO., LTD. | China | Public Company | WuXi Chemistry (small molecules, oligos, peptides, conjugates),WuXi Testing (toxicology, DMPK, bioanalytical),WuXi Biology (discovery biology and translational services), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Research Models and Services,Discovery and Safety Assessment,Manufacturing Solutions, |
| SGS SA | Switzerland | Public Company | Testing & Inspection,Certification & Assurance,Digital Trust & Consulting, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| MEDPACE HOLDINGS, INC. | United States | Public Company | Full-service clinical development (Phase I–IV),Central and bio-analytical laboratories,Imaging and ECG services, |
| SARTORIUS AG | Germany | Public Company | Bioprocess solutions (bioreactors, cell culture, fluid management, process filtration),Lab products and services (filtration, water systems, weighing, pipettes, microbiological testing),Analytical and PAT solutions (BLI, cytometry, live-cell imaging, SPR, data analytics), |
| ALS | France | Public Company | Rolling stock (metros, regional, high-speed, locomotives, people movers),Signaling (urban, mainline, freight and mining),Turnkey systems and infrastructure (APM, monorail, tram, metro, main line, electrification, track), |
PATHEON INC
Patheon Inc is a private pharmaceutical manufacturing company based in the Netherlands with 9,100 employees. The company provides contract development and manufacturing services to the pharmaceutical industry.
BIOMERIEUX S.A.
bioMérieux S.A. is a French public company founded in 1963 with 14,894 employees specializing in in vitro diagnostics and microbiology testing solutions. The company serves clinical, industrial, and food safety markets globally.
EXOVA GROUP PLC
Exova Group PLC is a United Kingdom-based private company founded in 2008 with 4,167 employees providing testing, inspection, and certification services. The company serves multiple industries including aerospace, automotive, and consumer products.
TSI INC
TSI Inc is a Chinese public company founded in 1903 with 29,257 employees operating across multiple industrial sectors. The company has a significant presence in manufacturing and related industries.
UNILABS
Unilabs is a Swiss private company founded in 1987 with 1,897 employees providing clinical laboratory and diagnostic services. The company operates across multiple European markets offering comprehensive testing solutions.
EUROFINS SCIENTIFIC SE
Eurofins Scientific SE is a Luxembourg-based public company founded in 1987 with 65,694 employees operating as a leading provider of laboratory testing and analytical services. The company serves pharmaceutical, food, environmental, and consumer product sectors globally.
INTERTEK GROUP PLC
Intertek Group PLC is a United Kingdom-based public company founded in 1885 with 45,425 employees providing quality assurance, testing, inspection, and certification services. The company serves diverse industries including oil and gas, chemicals, consumer goods, and electronics.
ICON PLC
ICON PLC is an Ireland-based public company founded in 1989 with 40,350 employees providing clinical research and development services. The company specializes in contract research organization services for the pharmaceutical and biotechnology industries.
IQVIA INC.
IQVIA Inc. is a United States-based public company with 93,000 employees providing integrated research, technology, and consulting services to the pharmaceutical and healthcare industries. The company offers clinical trial services, real-world data analytics, and healthcare consulting solutions.
WUXI APPTEC CO., LTD.
WuXi AppTec Co., Ltd. is a Chinese public company founded in 2000 with 33,834 employees providing contract research, development, and manufacturing services. The company serves the pharmaceutical, biotechnology, and chemical industries globally.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees providing preclinical and clinical laboratory services for drug development. The company specializes in safety assessment, bioanalytical testing, and research models.
SGS SA
SGS SA is a Swiss public company founded in 1878 with 83,000 employees operating as a leading provider of inspection, verification, testing, and certification services. The company serves industries including oil and gas, chemicals, consumer goods, and automotive.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees providing laboratory equipment, reagents, and analytical services. The company serves pharmaceutical, biotechnology, healthcare, and research markets globally.
MEDPACE HOLDINGS, INC.
Medpace Holdings, Inc. is a United States-based public company founded in 1992 with 6,300 employees providing clinical research and development services. The company specializes in contract research organization services for pharmaceutical and biotechnology companies.
SARTORIUS AG
Sartorius AG is a German public company founded in 1870 with 14,242 employees manufacturing laboratory and process technologies for the biopharmaceutical and food industries. The company provides equipment, consumables, and services for bioprocess applications.
ALS
ALS is a French public company founded in 1928 with 87,832 employees operating as a global provider of testing, inspection, and certification services. The company serves industries including mining, oil and gas, environmental, and consumer products.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 4916.8 Million |
| Canada | USD 453.6 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Validation : Quantified North American market at $690.7M (2025) with 11.2% CAGR through 2030. Validate investment decisions and revenue projections with region-specific data exceeding global growth rates.
- Regulatory Landscape Intelligence : Understand FDA and Health Canada compliance requirements driving testing demand. Identify regulatory trends shaping service specifications, pricing models, and competitive positioning across US and Canadian markets.
- Country-Level Market Breakdown : Access granular market data for US ($4,916.8M) and Canada ($453.6M) to tailor market entry strategies, resource allocation, and partnership development by jurisdiction and market maturity.
- Competitive Positioning Strategy : Benchmark your organization against North American market dynamics, identify white space opportunities in raw material testing, and develop targeted go-to-market strategies for pharmaceutical, biotech, and medical device segments.
- Investment & Expansion Planning : Support capital allocation decisions, M&A strategy, and facility expansion plans with evidence-based North American market forecasts and segment-specific growth drivers through 2030.
Frequently asked questions
What is included in Raw Material Testing Services?
Raw Material Testing Services encompasses analytical testing, quality control, identity verification, purity analysis, and microbial contamination detection for pharmaceutical and medical device raw materials.
Why is Raw Material Testing Services critical in healthcare?
Raw Material Testing Services ensures regulatory compliance, product safety, efficacy, and prevents contaminated or substandard materials from entering the manufacturing supply chain.
What technologies are used in Raw Material Testing Services?
Raw Material Testing Services utilizes HPLC, GC-MS, spectroscopy, microbial testing, elemental analysis, and advanced chromatography techniques for comprehensive material validation.
How much will Raw Material Testing Services grow by 2030?
Raw Material Testing Services is expected to grow from $690.7 million in 2025 to $1,176.6 million by 2030, representing an 11.2% compound annual growth rate.
Who are the primary users of Raw Material Testing Services?
Primary users of Raw Material Testing Services include pharmaceutical manufacturers, biotechnology companies, contract manufacturers, medical device producers, and nutraceutical firms.
RESEARCH METHODOLOGY
This study utilized both primary and secondary sources to analyze the healthcare analytical testing services market. Extensive secondary research was conducted, followed by primary research to validate findings with industry experts. Various methods were used to estimate the overall market size, including top-down and bottom-up approaches. Market segmentation and data triangulation were then applied to define different segments within the market. The research also explored influencing factors, key players, industry trends, competitive dynamics, and strategies of market participants.
Secondary Research
The secondary research process relies on various sources like directories, databases (e.g., Bloomberg Business, Factiva, D&B Hoovers), white papers, annual reports, company documents, investor presentations, and SEC filings. This research was essential for a detailed market analysis of healthcare analytical testing services, providing insights into key players and market segmentation trends. Additionally, it highlighted significant market and technology developments, leading to the creation of a database of industry leaders.
The market for healthcare analytical testing services is assessed using secondary data from various sources. This analysis reviews major companies' product portfolios and performance, providing insights into the industry's value chain, key players, and market segmentation from both market and technology perspectives.
Primary Research
In the primary research process for this report, various supply- and demand-side sources were interviewed to gather qualitative and quantitative data. Supply-side sources included industry experts like CEOs and key executives from prominent companies in healthcare analytical testing services. On the demand side, primary sources comprised OEMs, private testing organizations, and service providers. This research validated market segmentation, identified key players, and gathered insights on industry trends and dynamics.
Following market engineering, which involved calculations for statistics, breakdowns, and forecasting, we conducted extensive primary research to verify critical numbers. We identified market segmentation types, trends, and the competitive landscape while examining key dynamics such as drivers, restraints, opportunities, and challenges faced by major players.
In the comprehensive market engineering process, both top-down and bottom-up approaches were employed to estimate and forecast market segments. Extensive qualitative and quantitative analyses highlighted essential insights presented in the report.
A breakdown of the primary respondents is provided below:
Note 1: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were utilized to estimate and validate the healthcare analytical testing services market size and its segments. Revenue share analysis of leading players helped determine the global market size, with insights gathered from primary and secondary research. This included reviewing annual reports of top players and conducting interviews with key executives. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the global healthcare analytical testing services market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the market was validated using both top-down and bottom-up approaches.
Market Definition
The healthcare industry increasingly relies on healthcare analytical testing services to optimize the intricate processes involved in drug discovery and development and the testing of medical devices. These services play a crucial role for pharmaceutical, biopharmaceutical, and medical device companies by providing comprehensive analytical solutions that ensure the safety, efficacy, and quality of new therapies and devices.
Through advanced techniques such as mass spectrometry, chromatography, and molecular profiling, these analytical services enable the identification of active compounds, the assessment of biological responses, and the evaluation of product reliability. By streamlining workflows and ensuring regulatory compliance, these services accelerate the development timelines and enhance the overall effectiveness of clinical trials, ultimately leading to more successful market introductions and improved patient outcomes.
Stakeholders
- Healthcare Analytical Testing Service Providers
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Bioanalytical Testing Service Providers
- Environmental Testing Service Providers
- Contract Research Organizations (CROs)
- Medical Device Manufacturing Companies
- Academic Universities
- Research Institutes
- Research Laboratories
- Government Associations
- Cosmetic Companies
- Nutraceutical Companies
- Hospitals and Clinics
- Forensic Laboratories
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and forecast the healthcare analytical testing services market based on type, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global healthcare analytical testing services market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global healthcare analytical testing services market
- To analyze key growth opportunities in the global healthcare analytical testing services market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions: North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, Thailand, Singapore, Indonesia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
- To profile the key players in the global healthcare analytical testing services market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global healthcare analytical testing services market, such as agreements, expansions, and product launches
Get the Full Healthcare Analytical Testing Services Market Report
Full forecast, segment splits, and company analysis for all Healthcare Analytical Testing Services Market.
- US Healthcare Analytical Testing Services Market
- Canada Healthcare Analytical Testing Services Market
- Germany Healthcare Analytical Testing Services Market
- UK Healthcare Analytical Testing Services Market
- France Healthcare Analytical Testing Services Market
- Italy Healthcare Analytical Testing Services Market
- Switzerland Healthcare Analytical Testing Services Market
- Spain Healthcare Analytical Testing Services Market
- China Healthcare Analytical Testing Services Market
- Japan Healthcare Analytical Testing Services Market
- India Healthcare Analytical Testing Services Market
- South Korea Healthcare Analytical Testing Services Market
- Australia Healthcare Analytical Testing Services Market
- Brazil Healthcare Analytical Testing Services Market
- Mexico Healthcare Analytical Testing Services Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report